Personalized Immune Cell Treatment NKCL Classic
NKCL Bio Group, a Korean bio-company that research and develops immune cell therapy, is attracting attention as a beneficiary company of ‘the Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Bio-Pharmaceuticals' (hereinafter referred to as the Advanced Medicine Act). The ...
The Ministry of Food and Drug Safety and the Ministry of Health and Welfare announced on the 25th that the enactment of the Enforcement Decree of ‘The Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Biopharmaceuticals' has passed the cabinet meeting. The Advanced Regener...
As a company that researches immune cell therapy using NK immune cells, NKCL Bio Group targets the $100 billion Immune cell therapy market through its differentiated technological competitiveness. It is leading the mass production and popularization of NK Immune Cell and products through a GMP certif...
NKCL Bio Group has won 2020 Korea Future Management Award in Promising Bio company category. Korea Future Management is to discover and honor the people, companies, and organizations who have outstanding competence in various section of the society, which is organized by The Korea Herald, and Herald ...
Followed by ‘NK Blue Bio Series’, NKCL Bio Group launched ‘NK Cordycep Gold 300’, the anti-cancer and immunity enhancement functional food. ‘NK Cordycep Gold 300’ is a rice powder in which cordycepin is grown within the rice. Cordycepin is a major ingredient of Cordyceps Millitaris. It is known...
NKCL Bio Group has launched and started the sales of NK Blue Bio Cream that is effective on solving various skin problems. NK Blue Bio Series is composed with Blue Recombination Cream and Peel Mask and it is different from conventional cosmetic products. Normally the dead skin cells are removed first...
Construction site on May 9th Despite the delay in acquiring materials due to COVID-19 crisis, the construction went smoothly according to the plan. NKCL's GMP authorized Automated NK Cell Cultivation Center will not only act as a research and development, but also carry out office works and logistics...
Despite the delay due to not enough supply of the materials caused by COVID-19 crisis, the construction of ‘NK Cell GMP Automated Cultivation System’ is running smoothly according to the schedule. We share some of the footages of the construction site. NKCL Bio Group’s Automated Cultivation Center...
NKCL Bio Group and Labelle Clinic of Gwang-ju, Korea, had signed MOA on April 28th, agreeing upon delivering NK cell treatment. Labelle Clinic has 4 storied building with organized facilities. With director Park Tae-ho, many medical professionals and staff members are working in. Especially, Labelle ...
NKCL Bio Group Inc. (hereinafter referred to as ‘NKCL Bio Group’) is a Korean Bio Group company that researches and develops NK Immune cell treatment which utilizes NK immune cells. With its competitive technologies including cancer cell target treatment and Automatic NK Cell Cultivation System, NK...
